季度计划失败多因产能算术出错，而非优先级选择错误。 在B2B SaaS公司，这一点表现得尤为明显。关键数字是净收入留存率和CAC回本周期，而这个行业的特殊情况是增长率已从42%降至32%，同时60%的收入集中在经济效益最差的细分市场。通用问题和你实际面对的问题，起步动作并不相同。
季度计划失败多因产能算术出错，而非优先级选择错误。 在B2B SaaS公司，这一点表现得尤为明显。关键数字是净收入留存率和CAC回本周期，而这个行业的特殊情况是增长率已从42%降至32%，同时60%的收入集中在经济效益最差的细分市场。通用问题和你实际面对的问题，起步动作并不相同。
一个季度只有固定的工程人力和固定的获客现金，大多数计划却同时透支两者。结果不是直接失败，而是无声的筛选：团队继续服务已占60%收入的细分市场，而丢掉本可改善净收入留存率的落地与扩展动作。
能经得起现实检验的计划，会按净收入留存率和CAC回本周期对候选动作排序，再对照实际可用的工程和销售产能检查，最后排出顺序，让前一个动作能为后一个提供资金或解除阻塞。三个真实优先级，永远胜过十二个口头优先级。
几乎总是缺失的部分是停止规则——在细分市场毛利率或ACV上设定的观察阈值，用来判断动作是否失效。这个规则要在动作开始前就写好，而不是事后争论。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 上季度团队交付了面向现有客户的特性，而更高ACV细分市场的扩展机会无人触碰，也没有人记录这个取舍。
✓ 路线图同时列出了留存举措和新细分市场获取，却没有按CAC回本周期或净收入留存率排出顺序。
✓ 没有一个举措附带书面的毛利率或净收入留存率阈值，用来在数字未动时触发停止。
通常会让情况更糟的做法。 承诺所有看起来可能推动ARR的功能需求，这必然让团队把精力放在已占60%收入的细分市场，因为那些工单来得最快。
It is for you if you run or finance a B2B SaaS company and last quarter's plan was partly done and nobody formally dropped anything. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家B2B SaaS公司. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is TechNova Solutions, a sample company profile used for testing rather than a customer — $45M ARR, 280 engineers.
Excerpt from a real Percision run · Pricing Strategy · sample company profile
The move. Turn the 11-week implementation backlog into 50 reusable modules that lift services gross margin from 41 % to 55 % while preserving 23 % win rate.
| Investment required | $3.0-4.2 M total over 36 months |
| Expected return | Base case 3.8× cash-on-cash within 36 months |
| Revenue, year 1 | $47.8-49.2 M ARR |
| Revenue, year 2 | $51.5-54.0 M ARR |
| Revenue, year 3 | $56.0-60.0 M ARR |
| Exit criteria | Strategy abandoned if, by Month 12, template-able rule rate remains below 40 % OR if NRR of pilot cohort falls below 85 %; capital reallocated to Segment 2 analytics bolt-on. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For B2B SaaS公司 it works through net revenue retention, CAC payback, ACV by segment and gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
以实际产能为限，大多数中小企业的真实数字是两到三个。这个数字是算出来的，不是理念问题。
先按消耗产能的回报排序，再看可逆性。两者接近时，做能停掉的那一个。
停止规则就是为此准备的。提前约定失败条件的计划，可以凭证据调整，而不是靠争论，这是适应与漂移的区别。
Materially, yes. Growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are net revenue retention, CAC payback, ACV by segment, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on net revenue retention and CAC payback. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · Tiếng Việt · ไทย · हिन्दी · עברית